Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.[ Read More ]
The intrinsic value of one VVOS stock under the base case scenario is HIDDEN Compared to the current market price of 2.84 USD, Vivos Therapeutics, Inc. is HIDDEN
Current Assets | 2.46 M |
Cash & Short-Term Investments | 1.64 M |
Receivables | 202 K |
Other Current Assets | 616 K |
Non-Current Assets | 8.27 M |
Long-Term Investments | 0 |
PP&E | 4.7 M |
Other Non-Current Assets | 3.57 M |
Current Liabilities | 7.29 M |
Accounts Payable | 2.14 M |
Short-Term Debt | 948 K |
Other Current Liabilities | 4.2 M |
Non-Current Liabilities | 3.03 M |
Long-Term Debt | 1.52 M |
Other Non-Current Liabilities | 1.51 M |
Revenue | 13.8 M |
Cost Of Revenue | 5.53 M |
Gross Profit | 8.27 M |
Operating Expenses | 24.9 M |
Operating Income | -17.3 M |
Other Expenses | -3.71 M |
Net Income | -13.6 M |
Net Income | -13.6 M |
Depreciation & Amortization | 621 K |
Capital Expenditures | -803 K |
Stock-Based Compensation | 0 |
Change in Working Capital | 2.86 M |
Others | 27 K |
Free Cash Flow | -12.7 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
1 year ago
Jun 20, 2023
|
Bought 7.42 K USD
|
Huntsman Ronald Kirk
Chief Executive Officer |
+ 14000
|
0.53 USD |
1 year ago
Jun 16, 2023
|
Bought 2.65 K USD
|
Huntsman Ronald Kirk
Chief Executive Officer |
+ 5000
|
0.53 USD |
1 year ago
Jun 16, 2023
|
Bought 5.4 K USD
|
Huntsman Ronald Kirk
Chief Executive Officer |
+ 10000
|
0.54 USD |
1 year ago
Jun 15, 2023
|
Bought 10.5 USD
|
Huntsman Ronald Kirk
Chief Executive Officer |
+ 21
|
0.5 USD |
1 year ago
Jun 14, 2023
|
Bought 4.9 K USD
|
Huntsman Ronald Kirk
Chief Executive Officer |
+ 10000
|
0.49 USD |
1 year ago
Dec 23, 2022
|
Bought 10 K USD
|
Huntsman Ronald Kirk
Chief Executive Officer |
+ 20000
|
0.5 USD |
2 years ago
May 31, 2022
|
Bought 16.2 K USD
|
Huntsman Ronald Kirk
Chief Executive Officer |
+ 8000
|
2.03 USD |
3 years ago
Sep 21, 2021
|
Bought 21.5 K USD
|
Huntsman Ronald Kirk
Chief Executive Officer |
+ 5000
|
4.31 USD |
3 years ago
Aug 17, 2021
|
Bought 15 K USD
|
Huntsman Ronald Kirk
Chief Executive Officer |
+ 5000
|
3 USD |
3 years ago
May 25, 2021
|
Bought 5.29 K USD
|
Amman Bradford K.
Chief Financial Officer |
+ 1000
|
5.29 USD |
3 years ago
May 25, 2021
|
Bought 21.5 K USD
|
Huntsman Ronald Kirk
Chief Executive Officer |
+ 4000
|
5.38 USD |
3 years ago
Dec 24, 2020
|
Bought 7.38 K USD
|
Amman Bradford K.
Chief Financial Officer |
+ 1000
|
7.38 USD |
3 years ago
Dec 23, 2020
|
Bought 7.27 K USD
|
Huntsman Ronald Kirk
Chief Executive Officer |
+ 1000
|
7.2669 USD |
3 years ago
Dec 11, 2020
|
Bought 4.25 K USD
|
Huntsman Ronald Kirk
Chief Executive Officer |
+ 500
|
8.5 USD |